Pain News and Research

Latest Pain News and Research

New vacuum-like tool removes potentially deadly, large clots in hearts

Instead of making a chest incision for open heart surgery, cardiovascular surgeons can now use a new vacuum-like tool to remove potentially deadly, large clots that lodge in patients' hearts.

29 Jan 2014

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved the Company's supplemental new drug application for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE.

28 Jan 2014

Anxiety, depression and meditation: an interview with Dr Madhav Goyal, Johns Hopkins University School of Medicine

We wanted to be broadly inclusive of any kind of meditation program, so we defined a meditation program to be any kind of structured meditation program that involved at a minimum 4 hours of training, with instructions to practice outside the classroom.

28 Jan 2014

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.

28 Jan 2014

Neurologist receives Perl-UNC Neuroscience Prize for remarkable research on persistent brain activity

The UNC School of Medicine has awarded the 14th Perl-UNC Neuroscience Prize to Marcus Raichle, MD, a neurologist from Washington University in St. Louis who has made remarkable research findings about the persistent brain activity of our at-rest minds.

28 Jan 2014

Saint Luke receives $3.4M to investigate health benefits, cost-effectiveness of novel cardiac procedures

aint Luke's Mid America Heart Institute has been awarded a $3.4 million, three-year grant from Boston Scientific to investigate and better define the success, safety, health benefits, and cost-effectiveness of novel methods to open challenging blocked coronary arteries previously thought untreatable through minimally invasive techniques.

28 Jan 2014

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.

27 Jan 2014

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

27 Jan 2014

Organ and tissue donation saves lives

OneLegacy, the non-profit, federally designated organ, eye and tissue recovery agency serving the seven-country greater Los Angeles area, today issued the following statement: "Kim Pham, the 23-year-old woman who died from her injuries after being assaulted outside a Santa Ana nightclub on Jan. 18, saved five lives through the donation of her heart, kidneys, lungs, pancreas and liver to patients on the national organ transplant waiting list.

27 Jan 2014

New pain management system for patients with painful diabetic neuropathy

From the moment people learn to walk, many are taught that exercise is the key to living a healthy life. Indeed, the long-term benefits of exercise are indisputable.

25 Jan 2014

Antibe Therapeutics increases non-brokered private placement to a total of 2.27 million units

Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").

25 Jan 2014

Research roundup: Patient safety measure results 'disappointing'

Patient safety poses serious challenges to the health care system in the United States. Since 2001, nationwide efforts have focused on reducing in-hospital adverse events.

25 Jan 2014

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to have their aortic valves replaced trough traditional open-heart surgery.

25 Jan 2014

BIDMC aims to improve family engagement and reduce overall risk of harm in ICU

Beth Israel Deaconess Medical Center is embarking on a new phase of its mission to eliminate preventable harm, using information technology and system science together with patient and family engagement to head off harm before it happens.

25 Jan 2014

Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.

24 Jan 2014

Researchers locate two molecules involved in perpetuating chronic pain

Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.

24 Jan 2014

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which the organ is cooled with sterile ice during the operation.

24 Jan 2014

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week.

From Medtronic 24 Jan 2014

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Pfizer Inc. (NYSE: PFE) announced today top-line results from a Phase 3 study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic low back pain.

24 Jan 2014

Doctor offers tips to prevent injuries while shoveling snow

As temperatures continue to plunge and snowfall levels increase across the tri-state region, a physical therapy professor at University of the Sciences in Philadelphia reminds individuals the exertion, cold weather, and slippery surfaces snow shovelers face in these conditions are a dangerous combination.

24 Jan 2014

Pain News and Research

Latest Pain News and Research

New vacuum-like tool removes potentially deadly, large clots in hearts

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Anxiety, depression and meditation: an interview with Dr Madhav Goyal, Johns Hopkins University School of Medicine

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Neurologist receives Perl-UNC Neuroscience Prize for remarkable research on persistent brain activity

Saint Luke receives $3.4M to investigate health benefits, cost-effectiveness of novel cardiac procedures

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Organ and tissue donation saves lives

New pain management system for patients with painful diabetic neuropathy

Antibe Therapeutics increases non-brokered private placement to a total of 2.27 million units

Research roundup: Patient safety measure results 'disappointing'

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

BIDMC aims to improve family engagement and reduce overall risk of harm in ICU

Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Researchers locate two molecules involved in perpetuating chronic pain

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Doctor offers tips to prevent injuries while shoveling snow

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in